Skip to main content
Imlygic 1000000 [PFU]/mL injection, suspension by Amgen Inc
Imlygic, 1000000 [PFU]/mL, injection, suspension Available on prescription only. Listed by Amgen Inc.
Prescription only

Imlygic

talimogene laherparepvec

Listed by Amgen Inc

Strength
1000000 [PFU]/mL
Form
Injection, Suspension
Route
Intralesional

What it contains

  • Talimogene Laherparepvec 1000000 [PFU]/mL

FDA record

Dosage form Injection, Suspension
Route Intralesional
Approval route BLA — biologic licence
NDC code 55513-078
FDA application BLA125518
RxNorm concept 1721278
Package sizes listed 1
Marketed since November 2015

Other products containing Talimogene Laherparepvec

See all

Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.

Imlygic

talimogene laherparepvec

Strength
100000000 [PFU]/mL
Form
Injection, Suspension
Rx only

Amgen Inc

Not stocked by us — reference only

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.